PRDX2 and mantle cell lymphoma: We observed significantly higher PRDX2 mRNA levels in no-responder’s than in responder’s patients in the two independent series analyzed (Supplemental Figure S1), suggesting that PRDX2 might be involved in chemoresistance in MCL.